140 related articles for article (PubMed ID: 38352172)
21. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
Galli C; Maggi FM; Risé P; Sirtori CR
Br J Clin Pharmacol; 2012 Jul; 74(1):60-5. PubMed ID: 22242645
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects.
Goak IS; Lee JA; Jeong MH; Moon SJ; Kim MG
Drug Des Devel Ther; 2022; 16():4439-4448. PubMed ID: 36597442
[TBL] [Abstract][Full Text] [Related]
23. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State.
Maki KC; Palacios OM; Buggia MA; Trivedi R; Dicklin MR; Maki CE
Clin Ther; 2018 Dec; 40(12):2065-2076. PubMed ID: 30454850
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study.
Yang E; Yoo H; Jang IJ; Yu KS; Lee S
Drug Des Devel Ther; 2021; 15():651-658. PubMed ID: 33628012
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Cho S; Shim WS; Lee KT; Kim EH; Yang DH; Lee HW; Yoon YR
Drug Des Devel Ther; 2018; 12():3607-3615. PubMed ID: 30464392
[TBL] [Abstract][Full Text] [Related]
26. Effects of food on the pharmacokinetics of gemigliptin/metformin sustained-release 50/1,000 mg (25/500 mg x 2 tablets) fixeddose combination tablet in healthy male volunteers.
Choi HY; Noh YH; Kim YH; Kim MJ; Lee SH; Kim JA; Kim B; Lim HS; Bae KS
Int J Clin Pharmacol Ther; 2014 May; 52(5):381-91. PubMed ID: 24495314
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic Comparison Between a Fixed-Dose Combination of Empagliflozin L-Proline/Metformin and Empagliflozin/Metformin in Healthy Korean Subjects.
Lee H; Chung JY; Yu KS; Park SJ; Lee S
Clin Pharmacol Drug Dev; 2023 Dec; 12(12):1156-1163. PubMed ID: 37489552
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic Interaction between Atorvastatin and Omega-3 Fatty Acid in Healthy Volunteers.
Kim JH; Sunwoo J; Song JH; Seo YB; Jung WT; Nam KY; Kim Y; Lee HJ; Moon J; Jung JG; Hong JH
Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015110
[TBL] [Abstract][Full Text] [Related]
29. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
Offman E; Davidson M; Abu-Rashid M; Chai P; Nilsson C
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):815-825. PubMed ID: 28116646
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of atorvastatin and sustained-release metformin fixed-dose combination tablets: two randomized, open-label, 2-way crossover studies in healthy male subjects under fed conditions.
Choi YK; Park SE; Kim EY; Park HJ; Kim EJ; Song GS; Ghim JL
Transl Clin Pharmacol; 2017 Dec; 25(4):190-195. PubMed ID: 32095474
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men.
Choi HK; Ghim JL; Shon J; Choi YK; Jung JA
Drug Des Devel Ther; 2016; 10():3493-3499. PubMed ID: 27822013
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study.
Kim S; Ko JW; Kim JR
Clin Pharmacol Drug Dev; 2020 Apr; 9(3):386-394. PubMed ID: 31373174
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects.
Jin X; Kim E; Huh KY; Hwang I; Cho JY; Yu KS; Lee S
Transl Clin Pharmacol; 2020 Mar; 28(1):43-54. PubMed ID: 32274380
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects.
Min KL; Park MS; Jung J; Chang MJ; Kim CO
Clin Ther; 2017 Sep; 39(9):1799-1810. PubMed ID: 28803122
[TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacokinetics of a montelukast/levocetirizine fixed-dose combination chewable tablet versus individual administration of montelukast and levocetirizine after a single oral administration in healthy Korean male subjects
.
Moon SJ; Yu KS; Jung J; Kim YI; Kim MG
Int J Clin Pharmacol Ther; 2020 Jun; 58(6):354-362. PubMed ID: 32271144
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
.
Yoon S; Rhee SJ; Park SI; Yoon SH; Cho JY; Jang IJ; Lee S; Yu KS
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):533-539. PubMed ID: 28406090
[TBL] [Abstract][Full Text] [Related]
38. Effects of switching from omega-3-acid ethyl esters to icosapent ethyl in a statin-treated patient with elevated triglycerides.
Kedia AW; Lynch E
Postgrad Med; 2015; 127(8):869-73. PubMed ID: 26453247
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects.
Rhee SJ; Lee S; Yoon SH; Cho JY; Jang IJ; Yu KS
Drug Des Devel Ther; 2016; 10():1411-8. PubMed ID: 27110098
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of a fixed-dose combination of mitiglinide and metformin versus concurrent administration of individual formulations in healthy subjects: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover study.
Jung JA; Kim JR; Kim SR; Kim TE; Lee SY; Ko JW; Huh W
Clin Drug Investig; 2012 Dec; 32(12):799-804. PubMed ID: 23100167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]